Page 135 - AN-3-3
P. 135

Advanced Neurology                                            Delayed occlusion after mechanical thrombectomy



            in the right hemisphere. Given the high risk of ischemic   the use of any device,  and it should be noted that delayed
                                                                                17
            stroke in this area, we decided to proceed with an EC-IC   vascular stenosis and occlusion may still occur even with
            bypass surgery after a thorough discussion with the   the ADAPT method used, similar to our case. Vascular
            patient. This case was considered symptomatic MCA   stenosis after MT has been documented not only in cases
            occlusion due to the initial event. The superiority of EC-IC   with pre-existing stenotic lesions but also in cardioembolic
            bypass surgery over medical treatment for occlusion or   stroke cases where apparent vascular stenosis is not
            severe stenosis of intracranial arteries has not yet been   evident.  Therefore, diligent observation is warranted.
                                                                     18
            established.  However, it has been reported that patients
                     4,7
            with decreased cerebrovascular reactivity to acetazolamide   4. Conclusion
            are at high risk of recurrent ischemic stroke. 8-10  In the JET   We encountered a case where MT was performed for MCA
            study, a randomized controlled trial conducted in Japan,   occlusion. Following the procedure, reocclusion occurred
            surgical treatment significantly reduced the recurrence   in the chronic phase. The patient underwent an EC-IC
            rate of ischemic stroke compared to medical treatment in   bypass  surgery  and resumed work  without experiencing
            cases where quantitative cerebral blood flow evaluation   ischemic episodes. After MT, especially in cases with
            showed decreased cerebral blood flow at rest and reduced   residual stenosis, it is important to consider the potential
            cerebrovascular reactivity with an acetazolamide challenge   for delayed stenosis or occlusion.
            in the MCA territory.  Based on these findings, we
                               11
            determined that surgery was appropriate and performed   Acknowledgments
            the EC-IC bypass surgery.
                                                               None.
              There is ongoing debate about the treatment of ICAS.
            The SAMMPRIS trial compared aggressive medical     Funding
            management alone to aggressive medical management   None.
            combined with transluminal angioplasty and stenting for
            severe stenotic lesions of 70% or more, favoring aggressive   Conflict of interest
            medical therapy alone.  The VISSIT trial compared medical
                              5
            therapy alone with balloon-mounted stent placement for   The authors declare that they have no competing interests.
            lesions of 70% or more, showing a higher risk of stroke   Author contributions
            or  transient  ischemic  attack (TIA)  within 12  months  in
            the stent group compared to medical therapy alone.  In   Conceptualization: Hideki Kanamaru
                                                       12
            addition, the CASSIS trial compared medical therapy   Investigation: Hideki Kanamaru
            alone with medical therapy plus stent placement for non-  Writing – original draft: Hideki Kanamaru
            penetrating branch territory or non-disabling stroke cases   Writing – review & editing: Yoshinari Nakatsuka, Fumio
            with TIA but found no significant difference between   Asakura, Hiroto Murata
            the groups.  A systematic review encompassing  these
                     13
            randomized controlled trials concluded that, currently,   Ethics approval and consent to participate
            angioplasty or stent placement for symptomatic ICAS does   This study was approved by the Institutional Review Board
            not show superiority over medical therapy alone.  In our   (Approval Number: 2023-074). The patient consented to
                                                   14
            case, although the lesion was symptomatic and severe, the   participate, and written consent was obtained.
            patient did not undergo stent placement due to the lack of
            stenosis progression or recurrent ischemic episodes after   Consent for publication
            MT in the acute phase. However, if stenosis progression   Written consent was obtained.
            had been detected, stent placement could have been
            considered as a treatment option. ICAS following MT that   Availability of data
            employs previous-generation devices has been reported to
            occur in 8.8% of cases with more than 50% stenosis on MRI   Authors can provide data upon an appropriate request.
            3 months later.  Intracranial artery dissection may also be   References
                        15
            considered as a possible cause of progressive restenosis
            or occlusion. In a case series of spontaneous intracranial   1.   GBD 2019 Stroke Collaborators. Global, regional, and
            artery dissection, stenting was associated with the best   national burden of stroke and its risk factors, 1990-2019:
            rate of recanalization.  This pathology is also possible in   A systematic analysis for the Global Burden of Disease Study
                             16
            our case as a cause of delayed occlusion. In vitro studies   2019. Lancet Neurol. 2021;20(10):795-820.
            have shown that endothelial cell damage can result from      doi: 10.1016/s1474-4422(21)00252-0


            Volume 3 Issue 3 (2024)                         4                                doi: 10.36922/an.3332
   130   131   132   133   134   135   136   137   138   139   140